Reports synthesized ZnO nanoparticles and vitamin D production in Chlorella sp., highlighting sustainable applications.
An indigenous microalgae Chlorella sp. RSA402 was screened for integrated biomass and Extracellular polysaccharides (EPS) valorization. Growth kinetics revealed the mid-log phase on day 7, determined from cell density, dry biomass accumulation, and chlorophyll a content. Biomass, at this phase corresponded with elevated biochemical constituents, including protein (400±30.02 mgL⁻¹) and carbohydrate (250±12.05 mgL⁻¹) concentrations. UVB (Ultraviolet B) irradiation (295 nm) of day-7 biomass resulted in a vitamin D yield of 1.5 mg mg⁻¹ dry weight, as confirmed by HPLC analysis. EPS production reached 1.5±0.7 gL⁻¹, comprising 17.5±1.9% carbohydrates, protein (6.17±1.2%) and uronic acids (5±0.9%) respectively, and was employed as a sole biogenic capping and stabilizing agent for green synthesis of ZnO nanoparticles. The synthesized EPS-ZnO exhibited reduced crystallite size (8.58 nm) with enhanced colloidal stability (zeta potential −27.1 mV; hydrodynamic diameter 232 nm by DLS). FTIR analysis confirmed biomolecular functional group interactions during nanoparticle formation, while TGA demonstrated improved thermal resistance with minimal weight loss (9.15%). EDAX spectra validated the elemental purity of ZnO. The EPS–ZnO nanocomposite achieved 67.34±0.12% efficiency on diesel emulsification. Overall, the study represented a sustainable nutraceutical–nanotechnology integrated biorefinery framework.
No takes yet. Share an insight, caveat, or question.
Kanagathara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: